Who first thought of using Low Dose Naltrexone for MS?
Initial research on LDN was conducted by Ian S. Zagon, Ph.D., Professor of Neural and Behavioral Sciences at Pennsylvania State University. The use of LDN for MS is credited to Dr. Bernard Bihari, a practicing neurologist in New York. Dr. Bihari, who received his MD from Harvard and is board-certified in psychiatry and neurology, began prescribing LDN for his MS patients in 1985. (To read a transcript of a 1993 radio interview with Dr. Bihari, click on “Interview with Dr. Bihari” located on the menu at left.